Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II

NCT03125889 is registered in ClinicalTrials.gov with PROCEPT BioRobotics as lead sponsor.

NCT NCT03125889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03125889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II
Lead sponsor
PROCEPT BioRobotics
Phase
Not applicable
Overall status
Completed
Start date
April 10, 2017
Completion date
July 7, 2017
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia